NL Industries (NL) stock prices updated...

NL Industries stock price, NL

NL Industries stock chart:

NL Industries close price: 6.45

Stock price forecast:

UP TO +23.41%
Target: 7.96

Total forecasts: 89
Reached: 67 (75.28%)

Total Win: 53.28 (696.95%)

DaysForecastsReached%Reached points%InvestedUnreached%Total%

Showing 1-10 of 510 items.
Date of ForecastStock PriceTarget PriceForecast Reached Date

NL Industries latest news:

  • 03/22/2017 07:51:11

    Investors urge Dulux owner to hold takeover talks

    AkzoNobel says an improved offer from US rival PPG Industries is still too low.

  • 03/22/2017 05:18:39

    Dulux paint maker rejects second takeover offer

    Dutch company AkzoNobel says an improved offer from US rival PPG Industries is still too low.

  • 03/10/2017 10:31:06

    BRIEF-Eldridge Industries says its affiliate terminated deal to sell Dick Clark Productions to Dalian Wanda

    * One of its affiliates has terminated its agreement to sell dick clark productions to the dalian wanda group

  • 03/01/2017 16:47:58

    Merit-based immigration could upend industries

    Trump is proposing merit-based immigration, but it could hurt the industries that rely on low-skilled workers.        

  • 02/16/2017 11:26:33

    MHI rules out rescue of Toshiba’s nuclear business

    Mitsubishi Heavy Industries highlights differences between groups’ technologies

  • 02/15/2017 16:00:00

    BRIEF-Raven Industries posts Q3 earnings per share $0.16

    * Raven Industries reports strong third quarter fiscal 2017 results

  • 02/14/2017 10:38:24

    Allstate Program Could Bring Insurance Into the F&I Office

    Insurance and financing have traditionally been very separate businesses, but a division of The Allstate Corp. is testing a few pilot programs that could bring the two industries closer together, said Tom Capp, senior vice president of business development for the company’s Answer Financial division. Prime consumers, especially those lookingRead More

  • 02/08/2017 14:36:37

    BRIEF-State Street Corp reports a 6.81 pct passive stake in Polaris Industries

    * State Street Corp reports a 6.81 percent passive stake in polaris industries inc as of Dec. 31, 2016 Source text: ( Further company coverage:

  • 02/07/2017 12:45:59

    Teva CEO exits in ongoing crisis of confidence at drugmaker

    Teva Pharmaceutical Industries was left without a permanent chief executive on Tuesday after Erez Vigodman stepped down, leaving new management to restore confidence in the world's biggest generic drugmaker after a series of missteps.

  • 02/06/2017 15:05:01

    Teva Pharma shares slide on CEO departure

    Teva Pharmaceutical Industries Ltd. share slid in the extended session Monday after the Jerusalem-based drugmaker said Erez Vigodman would step down as chief executive effective immediately. Teva shares declined 1% to $34 after hours. The company said Yitzhak Peterburg, the company's chairman since January 2015, will serve as interim CEO, ceding his role as active chairman in accordance with Israeli law, Teva said. Board member Sol Barer was elected to serve as chairman. Teva said it has started a search for a permanent CEO.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit for more information on this news.

  • 02/02/2017 16:36:19

    Energy sector could see favor in NAFTA talks -Canada minister

    OTTAWA, Feb 2 (Reuters) - Canada's energy sector could find itself more favored than other industries when it comes time to renegotiating the North American Free Trade Agreement, Canadian Minister of Natural Resources Jim Carr said on Thursday.

  • 02/02/2017 14:46:03

    BRIEF-James Hardie Industries 9-mnth net profit up 8 pct

    * 9-mnth net profit US$ 232.0 million versus US$ 215.6 million

  • 01/30/2017 17:15:18

    Teva shares fall as court invalidates patent infringement claims

    Teva Pharmaceutical Industries Ltd. shares fell in the extended session Monday after a court did not uphold patent infringement claims made by the company. Teva shares fell 10% to $31 after hours. The court sided with Mylan NV , which claimed the patents in question were invalid. Mylan shares rose 0.7% to $36.60. The ruling from the U.S. District Court for the District of Delaware stated that the patents in contention, those covering Teva's multiple sclerosis treatment Copaxone, were not valid. Teva said it plans to appeal the decision. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit for more information on this news.

  • More trends:

    Noah Holdings Ltd.NOAH | Noble CorporationNE+3.95% | Noble Energy Inc.NBL | Nokia CorporationNOK-3.91% | Nomura Holdings Inc ADRNMR | Noranda Aluminum Holding CorporationNOR | Nord Anglia EducationNORD | Nordic American Offshore LtdNAO | Nordic American Tankers LimitedNAT | NordstromJWN+1.99% |